On Jun. 10, 1993, the NIH Revitalization Act of 1993, P.L. 103-43, was signed. The act encouraged the National Cancer Institute to expand and intensify its efforts in breast cancer and other women’s cancers and authorized increased appropriations. Similar language is included for prostate cancer. The institute is also directed to collaborate with the National Institute of Environmental Health Science (NIEHS), to undertake a case control study to assess biological markers of environmental and other potential risk factors contributing to the incidence of breast cancer in specific counties in the Northeast. In FY 1994 NCI is directed to allocate 7% of its appropriation to cancer control, in FY 1995, 9%, and in FY 1996, 10%.